ACAaron Chevalier

Aaron Chevalier

*This is an algorithmically generated author record based on publicly available information.

Aaron Chevalier has a total of 64 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Figure 5 from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    Lower activity of UV-associated mutations in cutaneous melanomas from Chinese patients. A, Bar plot of signature activities for seven melanomas in the OM cohort with at least 10 mutations that were included in the mutational signature analysis. B, The total number of SBS mutations per megabase (Mb), (C) the fraction of C>T mutations, and (D) the fraction of C>T mutations at the TCA, CCC, or TCT trinucleotide contexts were significantly lower in cutaneous melanomas from the Chinese cohort compared with cutaneous melanomas from the American cohort.

  • Open Access

    Figure 4 from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    SBS4 activity associated with sex but not smoking status in LUAD. A, SBS4 activity was predominantly observed in lung cancers, including LUAD, LUSC, and SCLC. Each stacked bar represents the estimated activity levels of each signature in each tumor. Signatures with no estimated activity in these tumor types were excluded. B, SBS4 activity was compared between three major types of lung cancer using the Wilcoxon rank-sum test. LUAD had significantly lower SBS4 activity than LUSC. C, The relationship between smoking status, sex, and EGFR mutation status is shown for a subset of LUADs with complete clinical information (n = 271). A higher proportion of males were observed in smokers compared with nonsmokers, and a higher proportion of EGFR mutations were observed in females compared with males in both smokers and nonsmokers. D, Using a Wilcoxon rank-sum test, SBS4 activity was significantly higher in males compared with females in both smokers and nonsmokers but was not significantly different between smokers and nonsmokers within males or within females. E, Using a multivariate linear model, SBS4 activity was associated with sex, sample type (i.e., lower in metastasis compared with primary), EGFR mutation status, and age. CI, confidence interval.

  • Open Access

    Figure 2 from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    Prevalence of aristolochic acid (SBS22) activity across tumor types. A, SBS22 reflects exposure to aristolochic acid and was highly active in 32 liver carcinomas/HCCs, six intra- or extrahepatic cholangiocarcinomas, three kidney renal cell carcinomas, and five urothelial carcinomas. This signature was also detected in four soft-tissue sarcomas and one esophageal carcinoma, which has not been reported in American and European cohorts. Each bar represents the level of the estimated signature activities in each sample, and samples are ordered by the level of SBS22. B, Using a multivariate linear model, SBS22 activity was associated with sex in urothelial carcinoma. C, SBS22 activity levels in urothelial carcinoma were higher in females compared with males. D, Mutation counts for two example liver carcinomas/HCCs, three soft-tissue sarcomas, and one esophageal carcinoma that predominantly contain the SBS22 signature. CI, confidence interval.

  • Open Access

    Supplementary Tables from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    Supplementary Tables from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

  • Open Access

    Supplementary Data from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

  • Open Access

    Figure 3 from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    Comparison of signature detection and activity levels across populations. A, Signatures with at least 10 counts in a tumor were considered detected in that tumor. The frequencies of detected signatures were compared across Chinese (OM) and American (MSK) cohorts using Fisher’s exact test with an FDR correction. Only tumor types with at least five tumors in each cohort were included. The majority of signature detection rates were not significantly different between cohorts, with the exception of the UV-associated signature SBS7, which was found in a higher proportion of soft-tissue sarcomas in the MSK cohort compared with the OM cohort. B, The median levels of proportional signature activities were compared for matched tumor types between the Chinese (OM) and American (MSK) cohorts using a Wilcoxon rank-sum test with an FDR correction. The majority of signature activities were not significantly different between cohorts with the exception of the apolipoprotein B mRNA editing catalytic polypeptide-like SBS2 signature in breast carcinoma, the SBS6 signature in colorectal carcinoma, and the SBS5 signature in HCC.

  • Open Access

    Data from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    The majority of mutational signatures have been characterized in tumors from American and European countries, and the degree to which mutational signatures are similar to or different from those in Chinese populations has not been fully explored. We leveraged a large-scale clinical sequencing cohort of tumors from the Chinese population developed by OrigiMed (OM). A total of 2,115 tumors from 25 major tumor types that had at least 10 single-base substitutions (SBS) were used for mutational signature analysis. Sixteen mutational signatures from the Catalogue of Somatic Mutations in Cancer (COSMIC) database were identified in the OM cohort using the musicatk package. The activity levels for most of the signatures were similar to those in a cohort from Memorial Sloan Kettering in the United States. The activity level for the apolipoprotein B mRNA editing catalytic polypeptide-like–related signature SBS2 was significantly lower in breast tumors in the OM cohort. The aristolochic acid signature SBS22 was observed in four soft-tissue sarcomas, and the POLE-associated signature SBS10 was observed in a gallbladder carcinoma. In lung adenocarcinoma, the polycyclic aromatic hydrocarbon signature SBS4 was significantly higher in males compared with females but not associated with smoking status. UV-related mutations were significantly lower in cutaneous melanomas from the Chinese cohort compared with the American cohort and may contribute to lower response rates to immunotherapy observed in this population. Overall, these results add to our understanding of the mutational processes that contribute to tumors from the Chinese population.Significance:Analysis of a large Chinese cohort from 25 tumor types reveals similarities and differences in the activity of mutational signatures compared with other populations.

  • Open Access

    Figure 1 from Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    The landscape of highly active mutational signatures in a large Chinese population. Sixteen mutational signatures were identified across 2,115 tumors from 25 tumor types. The size of the dot corresponds to the percentage of tumors within each tumor type that have detectable levels of the signature. Signatures with at least 10 counts were considered detected in an individual tumor. The color of the dot corresponds to the median activity of each signature within the detected samples per megabase (Mb).

  • Open Access

    Characterization of Mutational Signatures in Tumors from a Large Chinese Population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    The majority of mutational signatures have been characterized in tumors from American and European countries, and the degree to which mutational signatures are similar to or different from those in Chinese populations has not been fully explored. We leveraged a large-scale clinical sequencing cohort of tumors from the Chinese population developed by OrigiMed (OM). A total of 2,115 tumors from 25 major tumor types that had at least 10 single-base substitutions (SBS) were used for mutational signature analysis. Sixteen mutational signatures from the Catalogue of Somatic Mutations in Cancer (COSMIC) database were identified in the OM cohort using the musicatk package. The activity levels for most of the signatures were similar to those in a cohort from Memorial Sloan Kettering in the United States. The activity level for the apolipoprotein B mRNA editing catalytic polypeptide-like–related signature SBS2 was significantly lower in breast tumors in the OM cohort. The aristolochic acid signature SBS22 was observed in four soft-tissue sarcomas, and the POLE-associated signature SBS10 was observed in a gallbladder carcinoma. In lung adenocarcinoma, the polycyclic aromatic hydrocarbon signature SBS4 was significantly higher in males compared with females but not associated with smoking status. UV-related mutations were significantly lower in cutaneous melanomas from the Chinese cohort compared with the American cohort and may contribute to lower response rates to immunotherapy observed in this population. Overall, these results add to our understanding of the mutational processes that contribute to tumors from the Chinese population. Significance: Analysis of a large Chinese cohort from 25 tumor types reveals similarities and differences in the activity of mutational signatures compared with other populations.


  • Open Access

    Characterization of highly active mutational signatures in tumors from a large Chinese population

    by Aaron Chevalier, Tao Guo, Natasha Q. Gurevich, Jingwen Xu, Masanao Yajima, Joshua D. Campbell

    The majority of mutational signatures have been characterized in tumors from Western countries and the degree to which mutational signatures are similar or different in Eastern populations has not been fully explored. We leveraged a large-scale clinical sequencing cohort of tumors from a Chinese population containing 25 tumor types and found that the highly active mutational signatures were similar to those previously characterized 1,2 . The aristolochic acid signature SBS22 was observed in four soft tissue sarcomas and the POLE-associated signature SBS10 was observed in a gallbladder carcinoma. In lung adenocarcinoma, the polycyclic aromatic hydrocarbon (PAH) signature SBS4 was significantly higher in males compared to females but not associated with smoking status. The UV-associated signature SBS7 was significantly lower in cutaneous melanomas from the Chinese population compared to a similar American cohort. Overall, these results add to our understanding of the mutational processes that contribute to tumors from the Chinese population.